ATC codes:
L01BC05
Indication
Other specified malignant neoplasms of bronchus or lung
ICD11 code:
2C75.Y
INN
Gemcitabine
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IV:
200 mg in vial powder for injection ;
1 g in vial powder for injection
EML status history
First added in 2015
(TRS
994)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, gemcitabine was added to the complementary list of the EML for use in treatment protocols for non-small cell lung cancer. The relevant extract from TRS994 regarding the Expert Committee's consideration of treatment protocols for non-small cell lung cancer is attached.